Correction To: Fetuin-A is an immunomodulator and a potential therapeutic option in BMP4-dependent heterotopic ossification and associated bone mass loss

Bone Research

卷:10

Correction

Fang Ni¹  Haiming Wei¹  Haitao Fan²  Jiazhao Yang³  Shiyuan Fang³  Wanbo Zhu³  Yuanjuan Dai⁴  Ya Zhang⁴  Jia Liu⁴  Xiangyue Meng⁴  Rui Chen⁴  Xingxing Wang⁴  Siying Wang⁴  Jiao Zhou⁴  Guiling Li⁴  Hong Zheng⁴  Wei Wang⁴  Chen Kan⁵ 

[1] Department of Hematology, The First Affiliated Hospital of USTC, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China;Institute of Immunology, University of Science and Technology of China, Hefei, China;

[2] Department of Orthopaedics, Fuyang Hospital of Anhui Medical University, Fuyang, China;

[3] Department of Orthopaedics, The First Affiliated Hospital of USTC, Hefei, China;

[4] Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China;

[5] Department of Pathophysiology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China;Department of Hematology, The First Affiliated Hospital of USTC, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China;Institute of Immunology, University of Science and Technology of China, Hefei, China;

关键词: ;   

DOI  :  10.1038/s41413-022-00238-5

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2022